small molecule

ILLUCCIX

GALLIUM GA-68 GOZETOTIDE

Loss of exclusivityJuly 2035latest FDA-listed patent expiry

CompanyTELIX PHARMACEUTICALS US INC

Drug detail

Brand name	ILLUCCIX
Active ingredient	GALLIUM GA-68 GOZETOTIDE
Strength	N/A
Dosage form	POWDER
Route	INTRAVENOUS
Modality	Small molecule
FDA approval	December 2021
Marketing status	RX

Listed patents

Patent	Expires	Type
11027031	July 2035	use U-3317

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.